2015 American Society of Hematology Annual Meeting *

December 5-8, 2015; Orlando, Florida
This program provides coverage of the 2015 ASH annual meeting with PowerPoint summaries and expert analysis of the most clinically relevant study results with downloadable highlights slidesets. Topics include leukemias, lymphomas, myelodysplastic syndromes or myeloproliferative neoplasms, and multiple myeloma or other plasma cell disorders.

Share

Program Content

Activities

Mini-HCVD + Inotuzumab in ALL
Mini-HCVD + Inotuzumab Ozogamicin as Frontline Therapy in Older Adults With ALL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2015

Expires: December 05, 2016

AAML0631: ATO in Pediatric APL
AAML0631: Adding ATO to Consolidation Therapy in Pediatric APL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2015

Expires: December 06, 2016

GRAALL-R: Rituximab in BCP-ALL
GRAALL-R: Adding Rituximab to Chemotherapy Prolongs Event-Free Survival in CD20+, Ph-, B-Cell Precursor ALL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2015

Expires: December 06, 2016

ALFA-0702/CLARA: Clofarabine in AML
ALFA-0702/CLARA: Impact of Clofarabine Consolidation on DFS in Younger Adult Patients With Intermediate- or Unfavorable-Risk AML
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2015

Expires: December 07, 2016

Venetoclax + HMAs for Elderly Patients With AML
Venetoclax + Decitabine or Azacitidine in Elderly Treatment-Naive Patients With AML
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2015

Expires: December 08, 2016

Blinatumomab in R/R Ph+ B-Precursor ALL
ALCANTARA: Blinatumomab Shows Activity in R/R Ph-Positive B-Precursor ALL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2015

Expires: December 08, 2016

Radotinib vs Imatinib in CML
Radotinib vs Imatinib as Frontline Therapy for Newly Diagnosed Chronic-Phase CML
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2015

Expires: December 09, 2016

APL-2006: ATO in Standard-Risk APL
APL-2006: Role of Consolidation ATO in Standard-Risk APL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2015

Expires: December 09, 2016

Midostaurin in <i>FLT3</i>-Mutated AML
RATIFY: Midostaurin Added to Standard Chemotherapy Prolongs OS in Patients With Newly Diagnosed FLT3-Mutated AML
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2015

Expires: December 09, 2016

Ponatinib in T315I+ CML or ALL
Ponatinib vs AlloSCT in CML or Ph+ ALL With T315I Mutation
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2015

Expires: December 10, 2016

CTL019 in Pediatric ALL
Long-term Follow-up of CD19-Targeted CAR-T Cells (CTL019) in Pediatric Patients With Relapsed/Refractory ALL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2015

Expires: December 11, 2016

Blinatumomab in R/R B-Precursor ALL
Blinatumomab After AlloHSCT in Patients With R/R B-Precursor ALL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2015

Expires: December 12, 2016

Blinatumomab in MRD+ BCP ALL
Blinatumomab for MRD-Positive B-Cell Precursor ALL: An 18-Month Follow-up
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2015

Expires: December 12, 2016

Pracinostat + Azacitidine in Elderly AML
Pracinostat + Azacitidine in Elderly Patients With Newly Diagnosed AML
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2015

Expires: December 13, 2016

CAR T Cells in R/R B-Cell ALL
Evaluating Efficacy and Safety of Allo-SCT and Prognostic Value of MRD-Negative CR After 19-28z CAR T-Cell Infusion in Patients With R/R B-Cell ALL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2015

Expires: December 16, 2016

Downloadable Slideset
Acute and Chronic Leukemias
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 11, 2016

Expires: January 09, 2017

Activities

TEDDI-R With Ibrutinib in CNS Lymphoma
Phase I Study: Dose-Adjusted TEDDI-R With Ibrutinib in Primary CNS Lymphoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2015

Expires: December 06, 2016

Ibrutinib vs Temsirolimus in MCL
MCL3001 (RAY): Ibrutinib vs Temsirolimus in Previously Treated MCL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2015

Expires: December 07, 2016

Ibrutinib + Rituximab in FL
Ibrutinib Plus Rituximab in Treatment-Naive Patients With Follicular Lymphoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2015

Expires: December 08, 2016

NCI 9177: DA-EPOCH-R in BL
NCI 9177: Risk-Adapted DA-EPOCH-R in Adults With Burkitt Lymphoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2015

Expires: December 09, 2016

S1106: R-Bendamustine vs R-HyperCVAD in MCL
S1106: R-Bendamustine vs R-HyperCVAD Induction Therapy Followed by ASCT in MCL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2015

Expires: December 09, 2016

RESONATE-2: Ibrutinib in CLL
Phase III RESONATE-2: Frontline Ibrutinib vs Chlorambucil in Elderly Patients With CLL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2015

Expires: December 10, 2016

CALGB 50604: PET-Guided Treatment in HL
Phase II CALGB 50604: Choosing Chemo/Radiotherapy by PET Status in Hodgkin’s Lymphoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2015

Expires: December 10, 2016

Outcomes After KI Discontinuation in CLL
Outcomes of CLL Patients Treated With Alternate Kinase Inhibitors Following Ibrutinib or Idelalisib Discontinuation
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2015

Expires: December 10, 2016

PYRAMID: VR-CHOP in DLBCL
PYRAMID: Frontline R-CHOP ± Bortezomib in Non-GCB DLBCL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2015

Expires: December 10, 2016

Venetoclax in R/R del(17p) CLL
Venetoclax Monotherapy in R/R CLL With del(17p)
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2015

Expires: December 12, 2016

KEYNOTE-013: Pembrolizumab in Previously Treated cHL
KEYNOTE-013: Pembrolizumab in Classical Hodgkin’s Lymphoma After Brentuximab Vedotin Failure
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2015

Expires: December 12, 2016

ACP-196 in R/R CLL
ACE-CL-001: Investigation of ACP-196, a Second-Generation BTK Inhibitor, in R/R CLL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2015

Expires: December 13, 2016

BRESHAP Promising in R/R cHL
Brentuximab Vedotin + ESHAP in R/R Classical Hodgkin’s Lymphoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2015

Expires: December 13, 2016

Venetoclax + Rituximab for R/R CLL
Venetoclax + Rituximab in Relapsed/Refractory CLL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2015

Expires: December 14, 2016

Study 115: IDELA + BR for R/R CLL
Idelalisib ± Bendamustine/Rituximab in Relapsed/Refractory CLL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 17, 2015

Expires: December 15, 2016

Downloadable Slideset
Lymphomas
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 25, 2016

Expires: January 23, 2017

Activities

EQoL-MDS: Interim Results
EQoL-MDS: Eltrombopag in Low, Int-1 IPSS Risk MDS
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2015

Expires: December 05, 2016

PRM-151 in Myelofibrosis
Sustained 72-Week Efficacy With PRM-151 in Myelofibrosis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2015

Expires: December 06, 2016

Luspatercept in Lower-Risk MDS
PACE-MDS: Luspatercept Associated With Hematologic Improvement, Transfusion Independence in Lower-Risk MDS
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2015

Expires: December 06, 2016

Imetelstat in RARS/RARS-T
Telomerase Inhibition With Imetelstat in Refractory Anemia (RARS/RARS-T)
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2015

Expires: December 07, 2016

COMFORT-II: Ruxolitinib in MF
Ruxolitinib vs Best Available Therapy in Myelofibrosis: A 5-Year Follow-up of COMFORT-II
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2015

Expires: December 07, 2016

Ruxolitinib + Sonidegib in MF
Combination Ruxolitinib + Sonidegib in Myelofibrosis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2015

Expires: December 08, 2016

PegIFN2a in ET/PV: 7-Yr Data
Peginterferon α-2a in Essential Thrombocythemia and Polycythemia Vera: 7-Year Efficacy and Safety Data
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2015

Expires: December 08, 2016

PERSIST-1: Subgroup Analysis
PERSIST-1: Reduction in Spleen Volume and Symptom Scores in MF With Pacritinib vs BAT
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2015

Expires: December 08, 2016

Low-Dose HMAs in LR-MDS
Low-Dose Hypomethylating Agents Effective, Safe in Low/Int-1 Risk MDS
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2015

Expires: December 09, 2016

RUX + AZA in MDS/MPN
Ruxolitinib + 5-Azacitidine in Myelodysplastic/Myeloproliferative Neoplasms
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2015

Expires: December 10, 2016

Ruxolitinib + Pomalidomide in MF
MPNSG-0212: Ruxolitinib + Pomalidomide Clinically Active and Well Tolerated in MF
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2015

Expires: December 10, 2016

Prognostic Mutations in MDS
IWG-PM: Prognostic Significance of MDS-Associated Somatic Gene Mutations Independent of IPSS-R
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2015

Expires: December 11, 2016

Rigosertib + Azacitidine in MDS
Rigosertib + Azacitidine in Patients With Higher-Risk MDS
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2015

Expires: December 12, 2016

Pracinostat + AZA in MDS
Addition of Pracinostat to Azacitidine in Previously Untreated MDS
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2015

Expires: December 13, 2016

Downloadable Slideset
Myelodysplastic Syndrome and Myeloproliferative Neoplasms
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 11, 2016

Expires: January 09, 2017

Ruxolitinib + IFN-α2 in MPN
Danish COMBI Trial: Addition of Ruxolitinib to Interferon-α2 Therapy in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Activities

ELOQUENT-2: Elotuzumab + Rd in R/R MM
ELOQUENT-2: Elotuzumab + Len/Dex in R/R MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2015

Expires: December 05, 2016

VRd vs RD Induction in MM
SWOG S0777: VRd Vs Rd in Previously Untreated MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2015

Expires: December 05, 2016

Bortezomib in NDMM
HOVON-65/GMMG-HD4: Long-term Results for Bortezomib-Based Therapy in NDMM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2015

Expires: December 05, 2016

Ixazomib in Untreated MM
Ixazomib Plus Cyclo/Dex in Newly Diagnosed MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2015

Expires: December 06, 2016

IFM 2013-04: VTD vs VCD in MM
IFM 2013-04: VTD vs VCD Before ASCT in Patients With MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2015

Expires: December 07, 2016

Weekly Carfilzomib in RR MM
Phase I/II CHAMPION-1: Weekly Carfilzomib/Dexamethasone for Relapsed/Refractory Myeloma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2015

Expires: December 07, 2016

KEYNOTE-023: Pembro + Len/Dex in R/R MM
KEYNOTE-023: Pembrolizumab + Len/Dex in R/R MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2015

Expires: December 08, 2016

IMAJEM: PET/CT in MM
IMAJEM, a Substudy of IFM 2009: Prognostic Role of MRI and PET/CT in MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2015

Expires: December 09, 2016

Pembrolizumab + Pom/Dex in R/R MM
Phase II Study: Pembrolizumab + Pomalidomide/Dexamethasone for Patients With R/R MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2015

Expires: December 09, 2016

Ixazomib + Len/Dex in R/R MM
TOURMALINE-MM1: Improved PFS With Ixazomib + Len/Dex in R/R MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2015

Expires: December 09, 2016

Predictive Value of MRD in MM
Value of MRD to Predict PFS in MM: Results From IFM/DFCI 2009
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2015

Expires: December 10, 2016

Daratumumab + Pom/Dex in RR MM
Phase Ib MMY1001: Daratumumab Plus Pom/Dex in Patients With R/R MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2015

Expires: December 10, 2016

Anti-BCMA CAR T Cells Effective in MM
First-in-Human Trial: BCMA-Targeted CAR T Cells in Advanced R/R MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2015

Expires: December 14, 2016

Downloadable Slideset
Recent Updates in Multiple Myeloma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 19, 2016

Expires: January 17, 2017

Carfilzomib ± Filanesib in R/R MM
ARRAY-520-216: Phase II Trial of Carfilzomib With or Without Filanesib in R/R MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022
IFM 2009: RVD ± ASCT in Myeloma
IFM 2009: RVD ± Autologous Transplantation in Younger Patients With Newly Diagnosed MM
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

This activity is supported by independent educational grants from

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.